Lakeland Industries Inc income statement
In fiscal 2026, Lakeland Industries Inc reported revenue of $193m, up 15.2% on the year before, operating income of −$15.5m (a -8.1% margin) and net income of −$25.3m, or −$2.63 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2011Jan 2011 | 2012Jan 2012 | 2013Jan 2013 | 2014Jan 2014 | 2015Jan 2015 | 2016Jan 2016 | 2017Jan 2017 | 2018Jan 2018 | 2019Jan 2019 | 2020Jan 2020 | 2021Jan 2021 | 2022Jan 2022 | 2023Jan 2023 | 2024Jan 2024 | 2025Jan 2025 | 2026Jan 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 100 | 96 | 95 | 91 | 93 | 100 | 86 | 96 | 99 | 108 | 159 | 118 | 113 | 125 | 167 | 193 | 191 |
| Cost of revenue | — | — | — | — | — | — | — | 60 | 65 | 70 | 80 | 67 | 67 | 73 | 99 | 129 | 129 |
| Gross profit | 30 | 29 | 27 | 25 | 32 | 36 | 32 | 36 | 34 | 38 | 79 | 51 | 46 | 51 | 69 | 63 | 62 |
| Research and development | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — |
| General and administrative | 14 | 15 | 15 | 13 | 15 | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | 4 | 2 | −1 | −0 | 7 | 12 | 7 | 8 | 4 | 6 | 44 | 16 | 6 | 6 | −9 | −16 | −8 |
| Interest expense | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 |
| Provision for credit losses | — | — | — | — | 0 | 2 | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Income before tax | 2 | 1 | −21 | −3 | 3 | 11 | 6 | 8 | 3 | 6 | 44 | 16 | 5 | 9 | −18 | −18 | −10 |
| Income tax | 1 | −0 | 5 | −3 | −8 | 3 | 2 | 8 | 2 | 2 | 9 | 5 | 4 | 4 | −0 | 8 | 17 |
| Net income | 1 | −0 | −26 | −0 | 8 | 4 | 4 | 0 | 1 | 3 | 35 | 11 | 2 | 5 | −18 | −25 | −27 |
| Diluted EPS | $0.18 | −$0.07 | −$4.97 | −$0.02 | $1.33 | $0.53 | $0.53 | $0.06 | $0.18 | $0.41 | $4.34 | $1.41 | $0.24 | $0.72 | −$2.43 | −$2.63 | −$2.73 |
| Diluted shares (average) | 6m | 5m | 5m | 6m | 6m | 7m | 7m | 8m | 8m | 8m | 8m | 8m | 8m | 8m | 7m | 10m | 10m |
| EBITDA | 6 | 4 | 1 | 1 | 8 | 13 | 8 | 9 | 5 | 8 | 46 | 18 | 7 | 8 | −7 | −13 | −5 |
| Quarter | 2025 Q3Oct 2024 | 2025 Q4Jan 2025 | 2026 Q1Apr 2025 | 2026 Q2Jul 2025 | 2026 Q3Oct 2025 | 2026 Q4Jan 2026 | 2027 Q1Apr 2026 | 2027 Q2Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 47 | 47 | 52 | 48 | 46 | 47 | 50 |
| Cost of revenue | 27 | 28 | 31 | 34 | 33 | 31 | 33 | 32 |
| Gross profit | 19 | 19 | 16 | 19 | 14 | 15 | 15 | 19 |
| Operating income | 1 | −11 | −5 | −4 | −2 | −5 | 2 | −3 |
| Interest expense | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Income before tax | 0 | −19 | −5 | −4 | −2 | −6 | 2 | −4 |
| Income tax | 0 | −0 | −1 | −5 | 14 | 0 | 1 | 1 |
| Net income | 0 | −18 | −4 | 1 | −16 | −6 | 0 | −5 |
| Diluted EPS | $0.01 | −$2.48 | −$0.41 | $0.08 | −$1.64 | −$0.63 | $0.04 | −$0.50 |
| EBITDA | 2 | −11 | −3 | −3 | −0 | −6 | 4 | −2 |
Compare with peers
- Treace Medical Concepts, Inc. income statement
- Si-bone, Inc. income statement
- Neuronetics, Inc. income statement
- Establishment Labs Holdings Inc. income statement
- Cerus Corp income statement
Head to head: LAKE vs TMCILAKE vs SIBNLAKE vs STIM
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies